Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445107
Status:
COMPLETED
Last Update Posted:
2022-02-14
First Post:
2007-03-06
Brief Title:
SINGULAIR R as Complementary Therapy to Fixed Association Regimen 0476-363
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
An Open Label Observational Study to Assess The Efficacy Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STAR
Brief Summary:
The purpose of this study is to assess the treatment effect of montelukast 10mg on the primary endpoint of Asthma Control QuestionnaireACQ over a 8-week period in persistent asthma patients with or without allergic rhinitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_002 | None | None | None |